The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) today delivered a formal statement 1 to the United Nations General Assembly Hearings with NGOs, Civil Society and the Private Sector on the UN Millennium Development Goals. The IFPMA, the only industry body selected to make such a statement, outlined its members’ major contributions to the...
Read moreIndustry Commits to Submit for Scientific Journal Publication the Results of all its Phase III Clinical Trials The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today approved a “Joint Industry Position on the Publication of Clinical Trial Results in the Scientific Literature” 1 , previously approved by the European Federation of Pharmaceutical Industries and...
Read moreUN Millennium Development Goals Statement by Mario Ottiglio, Advocacy & External Relations Manager, IFPMA, to the 63rd World Health Assembly under Agenda item 11.4, Monitoring the Achievement of the UN MDGs Honorable Ministers, Your Excellencies, Madame Director General, Ladies and Gentlemen, The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents the global R&D pharmaceutical industry, whose...
Read moreCounterfeit Medical Products Statement by Eduardo Pisani, Director General of the IFPMA, to the 63rd World Health Assembly Honorable Ministers, Your Excellencies, Madame Director General, Ladies and Gentlemen, On behalf of the International Federation of Pharmaceutical Manufacturers and Associations, the IFPMA, I welcome the opportunity presented by the World Health Assembly to address the public health issue...
Read moreIFPMA Statement under WHA 63 agenda item 11.1 on Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits Delivered by Eduardo Pisani, Director General, IFPMA Check against delivery Honorable Ministers, Your Excellencies, Madame Director General, Ladies and Gentlemen, The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents the global R&D pharmaceutical industry, whose...
Read moreFight against Counterfeit Medicines to protect Patients’ Health The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today launched its Ten Principles on Counterfeit Medicines, to re-focus attention on this issue and underline the R&D-based pharmaceutical industry’s stance in the global fight against counterfeit medicines. Mr Haruo Naito, President of the IFPMA, and President...
Read moreIndustry Programs to improve Global Health increase to 213 The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) today published the latest edition of its “Developing World Health Partnerships Directory”. This resource, updated annually, documents the long-term public-private partnerships to improve health in developing countries which are supported by IFPMA member associations and companies*, almost...
Read more126th Session of the WHO Executive Board Agenda Item 4.1: Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits Delivered by Eduardo Pisani – check against delivery Mr Chairman, Madam Director General, distinguished members of the Executive Board, Excellencies, ladies and gentlemen, As new Director General of the International Federation...
Read moreEmergency Cash and Medicine Donations already amount to more than USD 16.9 million The research-based pharmaceutical industry represented by the IFPMA is providing significant emergency aid following the major earthquake that struck Haiti on 12 January. The total value of assistance provided so far by IFPMA member companies*, including both cash and donation of medicines...
Read moreThe R&D-based Pharmaceutical Industry’s response to the H1N1 influenza pandemic.
Read more